United StatesValisure, laboratorij za testiranje lijekova poznat po svojim sporovima s regulatorima oko nečistoća u lijekovima, tužio je američku Farmakopeju (USP), navodeći da je organizacija izdala lažne tvrdnje o svojim metodama testiranja.
Procjena pristranosti (Progresivno): U članku se konflikt između Valisurea i USP-a opisuje kao bitka oko znanstvene integritete i javnog zdravlja, naglašavajući potencijalne sukobe interesa USP-a.
Zašto činjenice (85): The article accurately reports that Valisure sued USP over allegations of false statements regarding their testing methods. It cites the lawsuit and mentions the 2023 white paper by USP as the basis for the claims. The details align with the cross-source consensus, though specific legal arguments an
Zašto objektivnost (75): The article presents the situation from Valisure's perspective but does not provide direct counterpoints from USP. While it avoids overtly biased language, it frames the dispute in a way that emphasizes Valisure's accusations without balancing them with potential responses from USP.
